Dr. Lewin is president and CEO of the Cardiovascular Research Foundation, a global enterprise focused on pre-clinical science, human clinical trials and interventional cardiology education.
Dr. Lewin will discuss the costs for medical innovation, regulatory scrutiny and time-to-market disadvantages.
More articles on spine:
Spine surgery for ‘Generation Me’: Will customization lead to better outcomes?
4 spine, neurosurgery practice expansions
Dr. Richard Francis develops patient-to-patient ambassador program
